Siren, L.L.C. Avidity Biosciences, Inc. Transaction History
Siren, L.L.C.
- $1.76 Trillion
- Q1 2025
A detailed history of Siren, L.L.C. transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Siren, L.L.C. holds 1,110,610 shares of RNA stock, worth $53.6 Million. This represents 1.87% of its overall portfolio holdings.
Number of Shares
1,110,610
Previous 1,127,295
1.48%
Holding current value
$53.6 Million
Previous $32.8 Billion
0.01%
% of portfolio
1.87%
Previous 1.45%
Shares
3 transactions
Others Institutions Holding RNA
# of Institutions
247Shares Held
116MCall Options Held
289KPut Options Held
998K-
Janus Henderson Group PLC London, X011.4MShares$551 Million0.19% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.3MShares$547 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA9.68MShares$467 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.24MShares$446 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY8.75MShares$422 Million4.23% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $2.52B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...